TY - JOUR
T1 - Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration
AU - Daftarian, Narsis
AU - Zandi, Souska
AU - Piryaie, Golbarg
AU - Nikougoftar Zarif, Mahin
AU - Ranaei Pirmardan, Ehsan
AU - Yamaguchi, Muneo
AU - Behzadian Nejad, Qurban
AU - Hasanpour, Hossein
AU - Samiei, Shahram
AU - Pfister, Isabel B.
AU - Soheili, Zahra Soheila
AU - Nakao, Shintaro
AU - Barakat, Aliaa
AU - Garweg, Justus G.
AU - Ahmadieh, Hamid
AU - Hafezi-Moghadam, Ali
N1 - Funding Information:
This work was supported by Juvenile Diabetes Research Foundation (JDRF) Innovation award (AHM) and the Malaysian Palm Oil Board (MPOB).
Publisher Copyright:
© 2020 Federation of American Societies for Experimental Biology
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Macrophages are the main infiltrating immune cells in choroidal neovascularization (CNV), a hallmark of the human wet, or neovascular age-related macular degeneration (AMD). Due to their plasticity and ability to adapt to the local microenvironment in a tissue-dependent manner, macrophages display polar functional phenotypes characterized by their cell surface markers and their cytokine profiles. We found accumulation of hemoglobin-scavenging cluster of differentiation 163 (CD163)(+) macrophages in laser-induced CNV lesions and higher expression of CD163(+) monocytes in the peripheral blood on day 7 post injury in mice. In comparison, CD80(+) macrophages did not differ with laser-injury in young or aged mice and did not significantly change in the peripheral blood of CNV mice. We examined the percentages of CD163(+), CD206(+), and CD80(+) monocytes in the peripheral blood of patients with wet AMD, patients with dry AMD, and in age-matched individuals without AMD as controls. Percentages of peripheral blood CD163(+) monocytes in both dry AMD (P <.001) and wet AMD (P <.05) were higher than in age-matched non-AMD controls, while there was no difference between the groups in the percentages of peripheral CD206(+) and CD80(+) monocytes. Further, serum level of soluble CD163 (sCD163) was elevated only in patients with wet AMD (P <.05). An examination of 40 cytokine levels across the study groups revealed that anti-VEGF treated patients with wet AMD, who showed no exudative signs on the day of blood drawing had a cytokine profile that was similar to that of non-AMD individuals. These results indicate that CD163 could be further evaluated for its potential as a useful marker of disease activity in patients with neovascular AMD. Future studies will address the origin and potential mechanistic role of CD163(+) macrophages in wet AMD pathologies of angiogenesis and leakage of blood components.
AB - Macrophages are the main infiltrating immune cells in choroidal neovascularization (CNV), a hallmark of the human wet, or neovascular age-related macular degeneration (AMD). Due to their plasticity and ability to adapt to the local microenvironment in a tissue-dependent manner, macrophages display polar functional phenotypes characterized by their cell surface markers and their cytokine profiles. We found accumulation of hemoglobin-scavenging cluster of differentiation 163 (CD163)(+) macrophages in laser-induced CNV lesions and higher expression of CD163(+) monocytes in the peripheral blood on day 7 post injury in mice. In comparison, CD80(+) macrophages did not differ with laser-injury in young or aged mice and did not significantly change in the peripheral blood of CNV mice. We examined the percentages of CD163(+), CD206(+), and CD80(+) monocytes in the peripheral blood of patients with wet AMD, patients with dry AMD, and in age-matched individuals without AMD as controls. Percentages of peripheral blood CD163(+) monocytes in both dry AMD (P <.001) and wet AMD (P <.05) were higher than in age-matched non-AMD controls, while there was no difference between the groups in the percentages of peripheral CD206(+) and CD80(+) monocytes. Further, serum level of soluble CD163 (sCD163) was elevated only in patients with wet AMD (P <.05). An examination of 40 cytokine levels across the study groups revealed that anti-VEGF treated patients with wet AMD, who showed no exudative signs on the day of blood drawing had a cytokine profile that was similar to that of non-AMD individuals. These results indicate that CD163 could be further evaluated for its potential as a useful marker of disease activity in patients with neovascular AMD. Future studies will address the origin and potential mechanistic role of CD163(+) macrophages in wet AMD pathologies of angiogenesis and leakage of blood components.
UR - http://www.scopus.com/inward/record.url?scp=85084064809&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084064809&partnerID=8YFLogxK
U2 - 10.1096/fj.201901902RR
DO - 10.1096/fj.201901902RR
M3 - Article
C2 - 32333612
AN - SCOPUS:85084064809
SN - 0892-6638
VL - 34
SP - 8001
EP - 8011
JO - FASEB Journal
JF - FASEB Journal
IS - 6
ER -